Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis

Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis

Background: Whether digoxin is associated with increased mortality in atrial fibrillation (AF) remains controversial. We aimed to assess the risk of mortality and clinical effects of digoxin use in patients with AF.Methods: PubMed, Embase, and the Cochrane library were systematically searched to ide...

Full description

Bibliographic Details
Main Authors:	Xiaoxu Wang, Yi Luo, Dan Xu, Kun Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	digoxin atrial fibrillation heart failure mortality readmission
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.731135/full

Similar Items

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
by: Antonella Colella, et al.
Published: (2022-06-01)

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
by: Alon Eisen, et al.
Published: (2017-07-01)

A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
by: Mohammad Afzali Moghadam, et al.
Published: (2012-08-01)

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
by: Toshinori Hirai, et al.
Published: (2022-02-01)

Digoxin for atrial fibrillation: good, but not too good: a case report
by: Gustavo Luiz Gouvêa de Almeida, et al.
Published: (2022-08-01)

Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation
by: Jong Ho Shin, et al.
Published: (2018-06-01)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
by: Marcin Wais, et al.
Published: (2024-04-01)

Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
by: Noppaket Singkham, et al.
Published: (2021-12-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
by: Kuan-Cheng Lai, et al.
Published: (2018-05-01)

Comparison of creatinine‐based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure
by: Masahiro Sakai, et al.
Published: (2023-02-01)

The effect of calcium in water hardness on digoxin plasma levels in an experimental rat model
by: Shabnam Shahsavand, et al.
Published: (2020-09-01)

Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Naqash J. Sethi, et al.
Published: (2017-04-01)

A case of sudden slow heart rate in a patient with atrial fibrillation – what could be the possible cause?
by: Jin Yi Goh, et al.
Published: (2023-07-01)

A pharmacokinetic study of digoxin holiday dosing practice in Egypt: A prospective-randomized trial
by: S.A. Alshabasy, et al.
Published: (2016-12-01)

Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta‐analysis
by: Pradyumna Agasthi, et al.
Published: (2019-04-01)

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
by: Kevin Y. Chang, et al.
Published: (2023-03-01)

Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
by: Cheng Liu, et al.
Published: (2021-09-01)

Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial
by: Michail Botis, et al.
Published: (2022-11-01)

Catheter Ablation Improves Mortality and Other Outcomes in Real‐World Patients With Atrial Fibrillation
by: Pil‐Sung Yang, et al.
Published: (2020-06-01)

Review: Failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy
by: Sridhar Rao Gona, et al.
Published: (2023-07-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction
by: Ben N. Mercer, et al.
Published: (2018-10-01)

Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation
by: Otilia Țica, et al.
Published: (2022-10-01)

Catheter Ablation for the Management of Atrial Fibrillation: An Update of the Literature
by: Shahana Hussain, et al.
Published: (2023-08-01)

Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study
by: Yu‐Sheng Lin, et al.
Published: (2017-07-01)

Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation
by: Umut Kocabaş, et al.
Published: (2020-04-01)

Increased mortality in patients with secondary diagnosis of atrial fibrillation: Report from Chinese AF registry
by: Xing‐Hui Shao, et al.
Published: (2020-09-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
by: Tianyu Xu, et al.
Published: (2019-06-01)

Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure
by: Ruxandra Nicoleta Horodinschi, et al.
Published: (2021-07-01)

HEART FAILURE PATIENTS ARE PRONE TO DEVELOP MAGNESIUM DEFIECIENCY AS A RESULT OF DIURETIC / DIGOXIN THERAPY
by: Surraiya Shaikh, et al.
Published: (2008-01-01)

HEART FAILURE PATIENTS ARE PRONE TO DEVELOP MAGNESIUM DEFIECIENCY AS A RESULT OF DIURETIC / DIGOXIN THERAPY
by: Surraiya Shaikh, et al.
Published: (2008-01-01)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
by: Yu‐Sheng Lin, et al.
Published: (2022-08-01)

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
by: Rivinius R, et al.
Published: (2016-02-01)

Pathophysiology of atrial fibrillation: From initiation to maintenance
by: Masatoshi Yamazaki, et al.
Published: (2012-06-01)

Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset
by: Matthew E. Oster, et al.
Published: (2016-01-01)

Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality
by: Ryan J. Field, et al.
Published: (2023-04-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)